Free Trial

Veracyte (VCYT) 10K Form and Latest SEC Filings 2026

Veracyte logo
$33.26 -0.19 (-0.57%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Veracyte SEC Filings & Recent Activity

Veracyte (NASDAQ:VCYT) has submitted 552+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Veracyte's financial statements. The most recent filing was a Form SCHEDULE 13G submitted on April 30, 2026.

Form 4
VERACYTE, INC. Reports Ownership Change on Apr. 14, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-K
Veracyte Files Annual Report on Feb. 26, 2026

The 10-K contains Veracyte's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Veracyte SEC Filing History

Browse Veracyte's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/30/2026 1:34 PM
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G
04/14/2026 4:03 PM
Haas Kevin Richard (1843872) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 12:53 PM
VANGUARD GROUP INC (102909) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
03/25/2026 3:50 PM
Haas Kevin Richard (1843872) Reporting
Veracyte (1384101) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 3:32 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:32 PM
Leite John (1991536) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:32 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:33 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 3:37 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2026 3:40 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2026 3:41 PM
Leite John (1991536) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2026 3:42 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 3:38 PM
Febbo Phillip G. (1649245) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 3:32 PM
Veracyte (1384101) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2026 12:40 PM
FMR LLC (315066) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
02/03/2026 1:00 PM
Artisan Partners Limited Partnership (1466153) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
01/12/2026 5:05 AM
Veracyte (1384101) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 8:21 AM
ARK Investment Management LLC (1697748) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
12/17/2025 3:35 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 3:30 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2025 3:34 PM
EASTHAM KARIN (1231845) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 3:26 PM
EASTHAM KARIN (1231845) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 6:43 PM
Veracyte (1384101) Issuer
Wygant Jonathan (1584145) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:43 PM
Leite John (1991536) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:44 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:44 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:44 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 6:44 PM
Febbo Phillip G. (1649245) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:38 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 3:39 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 3:39 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 3:27 PM
JONES EVAN/ FA (1020741) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2025 3:27 PM
Leite John (1991536) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 6:25 PM
JONES EVAN/ FA (1020741) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2025 3:28 PM
Leite John (1991536) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:19 PM
Holstein Jens (1819880) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:03 PM
Holstein Jens (1819880) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 5:15 AM
Artisan Partners Limited Partnership (1466153) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
11/10/2025 8:04 AM
STATE STREET CORP (93751) Filed by
STATE STREET CORP (93751) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G
11/05/2025 8:47 PM
JONES EVAN/ FA (1020741) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 3:17 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 3:18 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 3:18 PM
EASTHAM KARIN (1231845) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 10:49 AM
FMR LLC (315066) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
11/05/2025 7:15 AM
Veracyte (1384101) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2025 4:10 PM
ARK Investment Management LLC (1697748) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G
11/04/2025 3:08 PM
Veracyte (1384101) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2025 3:27 PM
Febbo Phillip G. (1649245) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2025 3:19 PM
Febbo Phillip G. (1649245) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:26 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:27 PM
Leite John (1991536) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:27 PM
EPSTEIN ROBERT S (1252004) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2025 3:18 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2025 3:25 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2025 3:33 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:45 PM
Chambers Rebecca (1823563) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:05 PM
Veracyte (1384101) Issuer
Wygant Jonathan (1584145) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:11 PM
Leite John (1991536) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:13 PM
Febbo Phillip G. (1649245) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:16 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 4:18 PM
McGuire Annie (1914620) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 3:26 PM
Stapley Marc (1539796) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025 9:34 AM
Veracyte (1384101) Subject
WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by
Form SCHEDULE 13G/A
08/12/2025 5:02 AM
Artisan Partners Limited Partnership (1466153) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
08/01/2025 1:20 PM
BlackRock, Inc. (2012383) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
06/23/2025 3:09 PM
Shafer David Brent (1728374) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:09 PM
Miller Thomas F. (2034921) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:09 PM
Bhanji Muna (1846905) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:09 PM
Barr Eliav (1940521) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:10 PM
EPSTEIN ROBERT S (1252004) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:10 PM
JONES EVAN/ FA (1020741) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:10 PM
Holstein Jens (1819880) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025 3:10 PM
EASTHAM KARIN (1231845) Reporting
Veracyte (1384101) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025 3:46 PM
Veracyte (1384101) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025 3:45 PM
Bhanji Muna (1846905) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025 3:46 PM
EASTHAM KARIN (1231845) Reporting
Veracyte (1384101) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025 2:04 PM
ARK Investment Management LLC (1697748) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
05/15/2025 6:11 AM
Artisan Partners Limited Partnership (1466153) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
05/14/2025 9:42 AM
ARK Investment Management LLC (1697748) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G
05/08/2025 7:06 AM
Veracyte (1384101) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2025 10:46 AM
ARK Investment Management LLC (1697748) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
05/07/2025 9:59 AM
FMR LLC (315066) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G/A
05/07/2025 9:43 AM
FMR LLC (315066) Filed by
Veracyte (1384101) Subject
Form SCHEDULE 13G
(Data available from 1/1/2016 forward)

Veracyte SEC Filings - Frequently Asked Questions

Veracyte (VCYT) has submitted 552+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Veracyte's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Veracyte's financial statements page.

The most recent filing was a Form SCHEDULE 13G submitted on April 30, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:VCYT) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners